n-formylmethionine leucyl-phenylalanine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jirillo, E; Livrea, P; Losito, S; Maffione, AB; Mitolo, V; Nacci, C; Ruggieri, M; Tatò, E; Troiano, M | 1 |
1 trial(s) available for n-formylmethionine leucyl-phenylalanine and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
In vivo effects of recombinant-interferon-beta1b treatment on polymorphonuclear cell and monocyte functions and on T-cell-mediated antibacterial activity in patients with relapsing-remitting multiple sclerosis.
Topics: Adult; Blood Bactericidal Activity; Candida albicans; Cell Separation; Colony-Forming Units Assay; Female; Humans; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Male; Monocytes; Multiple Sclerosis, Relapsing-Remitting; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phagocytosis; Recombinant Proteins; T-Lymphocytes | 2000 |